DOP031 Subtherapeutic serum infliximab trough levels and complete mucosal healing are associated with sustained clinical remission after infliximab discontinuation in paediatric Crohn's disease patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.